These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 31321610)
1. Delayed cut-end recurrence after wedge resection for pulmonary ground-glass opacity adenocarcinoma despite negative surgical margin. Sekihara K; Yoshida J; Oda M; Oki T; Ueda T; Ito T; Miyoshi T; Aokage K; Tane K; Tsuboi M Gen Thorac Cardiovasc Surg; 2020 Jun; 68(6):644-648. PubMed ID: 31321610 [TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules. Nakao M; Yoshida J; Goto K; Ishii G; Kawase A; Aokage K; Hishida T; Nishimura M; Nagai K J Thorac Oncol; 2012 Oct; 7(10):1563-6. PubMed ID: 22878750 [TBL] [Abstract][Full Text] [Related]
3. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller. Zhang C; He Z; Cheng J; Cao J; Hu J Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277 [TBL] [Abstract][Full Text] [Related]
5. The Effect of Resection Margin Distance and Invasive Component Size on Recurrence After Sublobar Resection in Patients With Small (≤2 Cm) Lung Adenocarcinoma. Moon Y; Park JK; Lee KY World J Surg; 2020 Mar; 44(3):990-997. PubMed ID: 31712844 [TBL] [Abstract][Full Text] [Related]
6. Sublobar Resection Margin Width Does Not Affect Recurrence of Clinical N0 Non-small Cell Lung Cancer Presenting as GGO-Predominant Nodule of 3 cm or Less. Moon Y; Lee KY; Moon SW; Park JK World J Surg; 2017 Feb; 41(2):472-479. PubMed ID: 27718002 [TBL] [Abstract][Full Text] [Related]
7. Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, intraoperatively diagnosed as Noguchi type B, in three patients. Yoshida J; Ishii G; Yokose T; Aokage K; Hishida T; Nishimura M; Onuki T; Noguchi M; Nagai K J Thorac Oncol; 2010 Apr; 5(4):546-50. PubMed ID: 20357619 [TBL] [Abstract][Full Text] [Related]
8. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma. Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952 [TBL] [Abstract][Full Text] [Related]
9. Surgical management of pulmonary adenocarcinoma presenting as a pure ground-glass nodule. Sim HJ; Choi SH; Chae EJ; Kim HR; Kim YH; Kim DK; Park SI Eur J Cardiothorac Surg; 2014 Oct; 46(4):632-6; discussion 636. PubMed ID: 24566849 [TBL] [Abstract][Full Text] [Related]
10. Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results. Yoshida J; Ishii G; Hishida T; Aokage K; Tsuboi M; Ito H; Yokose T; Nakayama H; Yamada K; Nagai K Jpn J Clin Oncol; 2015 Jul; 45(7):677-81. PubMed ID: 25900903 [TBL] [Abstract][Full Text] [Related]
11. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm. Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309 [TBL] [Abstract][Full Text] [Related]
12. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879 [TBL] [Abstract][Full Text] [Related]
13. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma. Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267 [TBL] [Abstract][Full Text] [Related]
14. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease. Gu B; Burt BM; Merritt RE; Stephanie S; Nair V; Hoang CD; Shrager JB Ann Thorac Surg; 2013 Aug; 96(2):411-8. PubMed ID: 23806231 [TBL] [Abstract][Full Text] [Related]
15. The role of the ground-glass opacity ratio in resected lung adenocarcinoma. Huang TW; Lin KH; Huang HK; Chen YI; Ko KH; Chang CK; Hsu HH; Chang H; Lee SC Eur J Cardiothorac Surg; 2018 Aug; 54(2):229-234. PubMed ID: 29471517 [TBL] [Abstract][Full Text] [Related]
16. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Sagawa M; Oizumi H; Suzuki H; Uramoto H; Usuda K; Sakurada A; Chida M; Shiono S; Abe J; Hasumi T; Sato M; Sato N; Shibuya J; Deguchi H; Okada Y Eur J Cardiothorac Surg; 2018 Apr; 53(4):849-856. PubMed ID: 29236995 [TBL] [Abstract][Full Text] [Related]
17. Management of Ground-Glass Opacities in the Lung Cancer Spectrum. Zhang Y; Fu F; Chen H Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031 [TBL] [Abstract][Full Text] [Related]
18. [Surgical experience of 6 multiple primary lung cancers]. Hara H; Ikeda C; Shimada M; Nagamine H; Sawa S; Oda M Kyobu Geka; 2008 Mar; 61(3):183-7. PubMed ID: 18323180 [TBL] [Abstract][Full Text] [Related]
19. Lung adenocarcinoma manifested as ground-glass nodules in teenagers: characteristics, surgical outcomes and management strategies. Ma Y; Fei X; Jiang C; Chen H; Wang Z; Bao Y Eur J Cardiothorac Surg; 2024 Aug; 66(2):. PubMed ID: 39073900 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma. Shigefuku S; Shimada Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Ikeda N Ann Surg Oncol; 2021 Jan; 28(1):148-156. PubMed ID: 32920721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]